AIIMS doc questions quality of hospital's life saving drugs

Image
Press Trust of India New Delhi
Last Updated : Mar 28 2014 | 8:00 PM IST
A department head of AIIMS has questioned the quality of life saving drugs available in the premier hospital and demanded a review of all those drugs procured, claiming the condition of her husband "deteriorated" after consuming one such medicine.
In her letter to the Medical Superintendent, Head of the Department of Anaesthesiology, Dr Chandralekha asked the hospital head to review stock of life saving drugs which are used in emergency situations quite often.
As per the letter, Dr Chandralekha's husband recently developed severe urticaria all over the body after consuming the some drugs from the hospital's store.
As his condition worsened he was prescribed heavy doses of anti-allergic drugs. The treatment went on for five days.
"Despite giving such heavy doses of all anti-allergic drugs, response to the treatment was not satisfactory, rather negligible," she said in her letter.
In view of this, the treatment was reviewed and it was decided to stop one of the tablets and change the brand and the new drug was purchased from the market," she said.
After that the condition of the patient started showing improvement.
"The problem could be detected just because we are living in the campus, having pool of doctors around us watching patient personally," Chandralekha said.
She said,"Samples are being sent to you duly signed by me, for review, and such spurious life saving drugs should be withdrawn and banned immediately."
"I am seriously concerned with the substandard life saving drugs," she said in her letter dated March 25.
According to the hospital sources, the samples have been sent for testing and one company has already been debarred.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 28 2014 | 8:00 PM IST

Next Story